InvestorsHub Logo
Followers 28
Posts 1440
Boards Moderated 0
Alias Born 12/18/2014

Re: Basin Street Blues post# 451281

Tuesday, 03/15/2022 11:32:55 AM

Tuesday, March 15, 2022 11:32:55 AM

Post# of 700021
Thanks. As a MRK shareholder I sure hope they eventually find a combination that improves the targeting of the immune system. As the unrestrained immune system repeatedly results in the grade 3 to 5 adverse events as seen in this trial. As a NWBO shareholder I hope trials with the combination L improves immune targeting.

Recovering former moderator.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News